Antiphospholipid Syndrome in Systemic Autoimmune Diseases. Questo articolo non è disponibile.Antiphospholipid Syndrome in Systemic Autoimmune Diseases

Antiphospholipid Syndrome in Systemic Autoimmune Diseases, Second Edition provides an overview of our current understanding of this major disease. It includes the latest information on the new pathogenetic mechanisms involved, along with clinical manifestations in both the thrombotic and non-thrombotic manifestations of this important disease.

Antiphospholipid syndrome is an autoimmune disease that causes abnormal blood clots. It is now recognized as a major cause of common conditions, including stroke, heart attack, miscarriage, epilepsy, and memory loss, and as such is gaining recognition in all branches of medicine, from obstetrics to cardiology, and from psychiatry to orthopedics.

Ricard Cervera, MD, PhD, FRCP is Senior Consultant Physician and Head at the Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Head of the Research Team on Systemic Autoimmune Diseases at the Institut d Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, and Professor at the Department of Medicine, Universitat de Barcelona. Barcelona, Catalonia, Spain, where he coordinates the Masters Course on Autoimmune Diseases. See: http://www.med.ub.es/MIMMUN/PERSONAL/CERVERA/CVCERVER.HTM

Gerard Espinosa, MD, PhD is Consultant at the Department of Autoimmune Diseases, Hospital Clínic, Barcelona, member of the Research Team on Systemic Autoimmune Diseases (coordinator of the Clinical Trials Unit) at the Institut d Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona and Associate Professor at the Department of Medicine, Universitat de Barcelona, Barcelona, Catalonia, Spain.

Munther Khamashta is Professor/Consultant Physician and Director of The Graham Hughes Lupus Research Laboratory at St Thomas Hospital, London, and runs a large lupus pregnancy clinic. He studied medicine in Barcelona and internal medicine in Madrid, Spain, where he developed an interest in connective tissue diseases and received his PhD. He was awarded the MRCP in 1999 and FRCP in 2002. He joined the Lupus Unit in London 25 years ago and has been instrumental in developing it into an internationally recognised tertiary centre receiving referrals from all over the UK, see https://kclpure.kcl.ac.uk/portal/en/persons/munther-khamashta(e30b3284-8df1-4cc2-9856-9bca61db843e)/biography.html